ABUSOLVE Trademark

Trademark Overview

On Friday, May 20, 2016, a trademark application was filed for ABUSOLVE with the United States Patent and Trademark Office. The USPTO has given the ABUSOLVE trademark a serial number of 87045791. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 18, 2019. This trademark is owned by Ardmore Therapeutics. The ABUSOLVE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and products, comprising one or more active pharmaceutical ingredients which has a potential for abuse and combined with one or more pharmaceutical excipients which make the resulting dosage form abuse deterrent or abuse resistant for delivery of a wide variety of therapeutic agents; abuse resistant and abuse deterrent pharmaceutical preparations and products, namely, psychotropics, antidepressants, anxiolytics, analgesics, opioids, CNS stimulants, depressants, hallucinogens, decongestants; abuse resistant pharmaceutical preparations and products acting on the central nervous system
abusolve

General Information

Serial Number87045791
Word MarkABUSOLVE
Filing DateFriday, May 20, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 18, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 22, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations and products, comprising one or more active pharmaceutical ingredients which has a potential for abuse and combined with one or more pharmaceutical excipients which make the resulting dosage form abuse deterrent or abuse resistant for delivery of a wide variety of therapeutic agents; abuse resistant and abuse deterrent pharmaceutical preparations and products, namely, psychotropics, antidepressants, anxiolytics, analgesics, opioids, CNS stimulants, depressants, hallucinogens, decongestants; abuse resistant pharmaceutical preparations and products acting on the central nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, May 26, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameArdmore Therapeutics
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 921289996
Party NameArdmore Therapeutics
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSan Diego, CA 921289996

Trademark Events

Event DateEvent Description
Tuesday, February 19, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 18, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, July 13, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 11, 2018EXTENSION 3 GRANTED
Wednesday, July 11, 2018EXTENSION 3 FILED
Wednesday, July 11, 2018TEAS EXTENSION RECEIVED
Wednesday, January 31, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, January 27, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 26, 2018EXTENSION 2 GRANTED
Wednesday, January 17, 2018EXTENSION 2 FILED
Thursday, January 25, 2018NOTICE OF REVIVAL - E-MAILED
Wednesday, January 24, 2018EXTENSION RECEIVED WITH TEAS PETITION
Wednesday, January 24, 2018PETITION TO REVIVE-GRANTED
Wednesday, January 24, 2018TEAS PETITION TO REVIVE RECEIVED
Friday, January 19, 2018ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
Friday, January 19, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 15, 2018TEAS EXTENSION RECEIVED
Friday, July 7, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 5, 2017EXTENSION 1 GRANTED
Wednesday, July 5, 2017EXTENSION 1 FILED
Wednesday, July 5, 2017TEAS EXTENSION RECEIVED
Tuesday, January 17, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 22, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 22, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 2, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, October 7, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 20, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, September 19, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, September 19, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 19, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 19, 2016NON-FINAL ACTION E-MAILED
Monday, September 19, 2016NON-FINAL ACTION WRITTEN
Tuesday, September 13, 2016ASSIGNED TO EXAMINER
Tuesday, September 6, 2016ASSIGNED TO EXAMINER
Thursday, May 26, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 24, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

abusolve abuse pharmaceutical products resistant preparations which more deterrent analgesics anxiolytics